How Did HIV Transfer From Chimpanzees to Humans?

HIV crossed from chimpanzees to humans through direct exposure to infected blood, most likely during the hunting and butchering of wild chimpanzees in what is now southeastern Cameroon. The virus that became HIV-1 group M, responsible for the vast majority of infections worldwide, descends from a strain of simian immunodeficiency virus (SIVcpz) carried by a subspecies of chimpanzee in that region.¹ But a single moment of blood-to-blood contact between a hunter and a chimpanzee is only the beginning of the story. The pandemic required a chain of circumstances stretching across decades, geography, and colonial history to take hold.

The Source in Southeastern Cameroon

Researchers have traced the immediate ancestor of pandemic HIV-1 to chimpanzees of the subspecies Pan troglodytes troglodytes, which inhabit the forests of west-central Africa. By collecting and genetically analyzing fecal samples from wild chimpanzee communities, scientists identified SIVcpz strains in southeastern Cameroon that are the closest known relatives of HIV-1 group M.¹ The geographic precision matters: not just anywhere in Africa, and not just any chimpanzee population, but specific communities in a specific corner of Cameroon.

SIVcpz itself is not native to chimpanzees in the way many assume. Chimpanzees acquired their own version of SIV from smaller monkeys they prey on, creating a mosaic virus assembled from pieces of at least two different monkey viruses. That recombinant virus became SIVcpz, and it circulated among chimpanzee populations for centuries before one particular strain found its way into a human host.

More Than a Single Cut

The popular shorthand for how HIV jumped species is the “cut hunter” scenario: a person hunting or butchering a chimpanzee sustained a wound, infected chimpanzee blood entered their bloodstream, and the virus took hold. That image is useful as a sketch, but researchers have argued it is both a historical oversimplification and an ecological one. A 2016 study in EcoHealth pointed out that this framing relies on a narrow view of human-chimpanzee interactions and cannot, by itself, explain why the virus became a pandemic rather than a dead-end infection.²

The reality is that people in central African forests had been exposed to chimpanzee blood for millennia through hunting, butchering, and preparation of bushmeat. If a single cut were enough to launch a pandemic, it would have happened far earlier. What changed in the late nineteenth and early twentieth centuries was the broader context: colonial labor practices displaced large numbers of people, new settlements formed near forests, and growing urban centers created conditions where a virus that might previously have infected one person and fizzled out could instead spread person to person and gain a foothold. The initial cross-species jump was necessary but not sufficient. The pandemic required amplification.

When the Jump Happened

Pinpointing the exact moment SIVcpz became HIV-1 in a human body is impossible, but molecular clock methods give a useful window. By comparing the genetic sequences of SIVcpz strains in chimpanzees with early HIV-1 group M sequences and calculating how fast the virus mutates, researchers estimated that the most recent common ancestor of HIV-1 group M and the SIVcpz lineage closest to it dates to roughly 1853, with a range spanning from about 1799 to 1904.³ That date represents the maximum age for the introduction into humans; the actual jump could have come later.

Separately, analyses of early HIV-1 archival samples have helped researchers estimate when the virus began diversifying inside the human population. Two of the oldest known HIV-1 specimens come from Kinshasa (then Léopoldville, Belgian Congo): one from 1959 and another from 1960. The 1960 sample, recovered from a preserved lymph node biopsy, was genetically quite different from the 1959 sample, which tells us that HIV-1 had already been diversifying in humans for a considerable period before either sample was collected.⁴ Relaxed molecular clock analyses that incorporate both archival samples place the common ancestor of all group M viruses near the beginning of the twentieth century. A 2014 study in Science zeroed in further, concluding that Kinshasa was the focus of early HIV-1 transmission from the 1920s onward and the source from which pandemic viruses spread to other locations before 1960.⁵

A near-complete HIV-1 genome recovered from a 1966 tissue specimen in Kinshasa added further resolution, representing the oldest near-full-length genome of HIV-1 recovered to date and falling on a branch that is a non-recombinant sister lineage to what would become subtype C.⁶ Together, these archival sequences paint a picture of a virus that was already diversifying extensively in Kinshasa decades before anyone recognized AIDS as a disease in the early 1980s.

Why Kinshasa Became the Epicenter

The virus likely made its initial jump in or near the forests of southeastern Cameroon, but the pandemic did not ignite there. It ignited roughly 700 miles to the southeast, in the booming colonial city of Léopoldville. How it got there probably involved the movement of infected individuals along river trade routes that connected remote forest communities to the growing urban center on the Congo River.

Once in Léopoldville, the virus found ideal conditions for sustained spread. The city was one of the best-connected in central Africa, and by the late 1940s over a million people were passing through its railway system each year.⁷ Rapid urbanization brought together large numbers of people in close quarters, and the social disruptions of colonial rule created conditions favorable to sexual transmission: labor migration separated families, commercial sex work expanded, and public health infrastructure was sparse. The 2014 Science study emphasized the role of social changes and transport networks in establishing the virus in human populations.⁵

From Kinshasa, HIV-1 group M spread along railway lines to mining towns in the southern Congo and to other cities in the region. By the time independence movements swept across central Africa in the 1960s, the virus had seeded itself in multiple locations, setting the stage for the broader epidemic that would eventually reach every continent.

The Role of Unsterile Medical Practices

One factor that likely helped the virus gain traction during its earliest decades in humans was the reuse of unsterilized needles and syringes during colonial-era public health campaigns. Between the 1880s and the 1940s, European colonial governments in central Africa ran mass injection campaigns to treat diseases like sleeping sickness, yaws, malaria, and syphilis. These campaigns often involved injecting large numbers of people with inadequately sterilized equipment.⁸

If even a small number of people were carrying HIV-1 during these campaigns, reused needles could have transmitted the virus to dozens or hundreds of others in a short time. This kind of serial passage through human hosts could also have helped the virus adapt more quickly to the human immune system, accelerating its evolution from a poorly adapted zoonotic infection into a pathogen capable of efficient person-to-person spread. The evidence here is circumstantial rather than definitive, but the timeline fits: the molecular dating of early HIV-1 diversification overlaps with the peak period of these colonial medical campaigns.

Molecular Hurdles the Virus Had to Clear

Jumping from one species to another is not as simple as a virus entering a new host’s bloodstream. Primate cells have built-in antiviral defenses, sometimes called restriction factors, that can block foreign viruses. For SIVcpz to become HIV-1, it had to overcome several of these molecular barriers in human cells.

One well-studied example involves a protein called tetherin, which normally traps newly made virus particles on the surface of infected cells and prevents them from spreading. SIVcpz uses a protein called Nef to counteract chimpanzee tetherin, but human tetherin is structured differently, and Nef does not work against it. HIV-1 group M solved this problem by evolving a different viral protein, Vpu, which gained the ability to counteract human tetherin. Research on the molecular evolution of Vpu has identified specific motifs in its structure that are critical for this anti-tetherin activity.⁹ The ability of group M’s Vpu to efficiently counteract human tetherin may be one reason this particular lineage spread so much more successfully than the other HIV-1 groups. The virus did not just have to get into humans; it had to learn to replicate efficiently once there. Those host restriction factors acted as evolutionary filters, and only a virus that cleared them all could sustain human-to-human transmission.¹

Not Just Chimpanzees, and Not Just One Virus

The popular narrative focuses on chimpanzees and HIV-1, but the full picture involves multiple primate species and multiple cross-species transmissions. HIV-1 itself is not a single lineage. It comprises four groups: M, N, O, and P, each representing a separate jump from a primate host into humans.

Groups M and N both came from chimpanzees. Group M, as described above, is the pandemic strain. Group N is extremely rare, found in only a handful of people in Cameroon, and its ancestor SIVcpz lineage diverged from the group M ancestor around 1921.³

Groups O and P, by contrast, came from western lowland gorillas, not directly from chimpanzees. Gorillas themselves acquired SIV from chimpanzees at some earlier point, and the gorilla-adapted virus (SIVgor) then jumped to humans separately. Researchers sequenced gorilla viruses from Cameroon that were closely related to both HIV-1 group O and group P, confirming gorillas as the immediate source of these lineages. Group O has infected an estimated 100,000 people, mostly in west-central Africa, making it a significant epidemic in its own right though far smaller than group M.¹⁰ Group P has been found in only two people.

Then there is HIV-2, an entirely separate virus that causes a milder and less transmissible form of the disease. HIV-2 did not come from chimpanzees or gorillas at all. It descended from SIVsmm, a virus carried by sooty mangabeys, a smaller monkey species found in West Africa. This too was not a single event: HIV-2 has at least eight recognized groups, representing multiple independent cross-species transmissions from sooty mangabeys to humans.¹¹ Studies of wild sooty mangabey populations in Côte d’Ivoire found SIVsmm prevalence as high as roughly 59%, and evolutionary analyses showed that the mangabey strains clustered with five of the eight HIV-2 groups, including the two epidemic groups A and B, suggesting the eastern part of the sooty mangabey’s range as the likely geographic origin of those human infections.¹¹

The broader point is striking: cross-species transmission of primate immunodeficiency viruses into humans has happened at least a dozen separate times. The overwhelming majority of those events led to viruses that infected very few people and never spread widely. Only HIV-1 group M became a true pandemic, and understanding why it succeeded where others did not is one of the central questions in the field.

Why Only One Lineage Became a Pandemic

Given that so many independent cross-species jumps occurred, the obvious question is why group M exploded while the others remained contained. The answer is probably a combination of viral biology and historical accident.

On the biological side, group M acquired specific adaptations that made it better at replicating in and transmitting between humans. The Vpu-mediated tetherin antagonism discussed earlier is one piece. Group M viruses also appear to use human immune cell receptors more efficiently than the other groups, giving them a replication advantage. These molecular differences are real but subtle. They help explain sustained transmission but do not fully account for the scale of the pandemic.

On the historical side, group M had the misfortune, from the human perspective, of arriving in the right place at the right time for explosive spread. It reached Kinshasa during a period of massive demographic upheaval. The colonial-era conditions that amplified transmission, including urbanization, population mixing, sex work, and unsterile medical practices, were not unique to Kinshasa, but Kinshasa had all of them at once, combined with transport connectivity that allowed the virus to seed other cities. Other HIV lineages may have emerged in more isolated settings where opportunities for onward transmission were limited. Group O, for instance, became a regional epidemic in west-central Africa but never achieved global reach, possibly because it entered humans in a setting with less connectivity or because its biology made it slightly less transmissible.

The Debunked Polio Vaccine Theory

In the late 1990s, journalist Edward Hooper proposed that HIV-1 entered humans through contaminated oral polio vaccines prepared using chimpanzee kidney cells and administered in the Belgian Congo in the late 1950s. The hypothesis attracted significant public attention and genuine scientific investigation. Researchers tested it directly by examining SIVcpz strains in wild chimpanzee populations near the vaccine production site. The results were clear: while SIVcpz was indeed present in chimpanzees in that region, the circulating virus was genetically distinct from all strains of HIV-1, ruling out those chimpanzees as the source of the human pandemic.¹²

Independent analyses of the vaccine itself, retained samples of which were found in freezers, detected no trace of SIVcpz or chimpanzee DNA. And the molecular clock dating, which places the common ancestor of HIV-1 group M decades before the polio vaccine trials, made the timeline incompatible. The theory is now considered thoroughly refuted by the scientific community, though it still circulates in some corners of the internet.

Ongoing Exposure and Future Risk

People in central Africa continue to have physical contact with nonhuman primates through hunting, butchering, and keeping them as pets. A study examining patterns of human exposure to primate bodily fluids across central Africa found frequent physical contact across adult populations, with greater contact involving monkeys than apes, particularly during meat handling.¹³ This means the conditions that originally allowed SIV to cross into humans still exist.

Dozens of SIV strains circulate in African primates, and occasional human infections with novel strains are detected through surveillance programs. Most of these infections appear to be dead ends, not spreading efficiently from person to person. But the history of HIV demonstrates that under the right circumstances, a dead-end infection can become an epidemic. Deforestation pushes people into closer contact with primate populations, and growing bushmeat trade can expose urban populations to viruses they would not otherwise encounter. Surveillance of primate viruses and the people who come into contact with them is one of the main strategies for catching the next potential spillover early, before it has a chance to find its Kinshasa.

1
PubMed Central. Origins of HIV and the AIDS pandemic
2
PubMed. Beyond the Cut Hunter: A Historical Epidemiology of HIV Beginnings in Central Africa
3
PubMed Central. Dating the Age of the SIV Lineages That Gave Rise to HIV-1 and HIV-2
4
PubMed Central. Direct evidence of extensive diversity of HIV-1 in Kinshasa by 1960
5
PubMed Central. The early spread and epidemic ignition of HIV-1 in human populations
6
bioRxiv. A near-full-length HIV-1 genome from 1966 recovered from formalin-fixed paraffin-embedded tissue
7
BMJ. HIV pandemic originated in Kinshasa around 1920, say scientists
8
PubMed Central. Conflicting Views in Narratives on HIV Transmission via Medical Care
9
PubMed Central. Possible Acquisition and Molecular Evolution of vpu Genes Inferred from Comprehensive Sequence Analysis of Human and Simian Immunodeficiency Viruses
10
PubMed Central. Origin of the HIV-1 group O epidemic in western lowland gorillas
11
PubMed Central. Simian immunodeficiency virus infection in free-ranging sooty mangabeys (Cercocebus atys atys) from the Taï Forest, Côte d’Ivoire: implications for the origin of epidemic human immunodeficiency virus type 2
12
PubMed. Origin of AIDS: contaminated polio vaccine theory refuted
13
PubMed Central. Using physical contact heterogeneity and frequency to characterize dynamics of human exposure to nonhuman primate bodily fluids in central Africa